STEM CELLS GOING TO THE DOGS (Orthopedics This Week)
Aratana Therapeutics, Inc. has entered into an agreement to develop and commercialize a novel stem cell therapy for dogs. The licensor, Vet-Stem, Inc., pioneered the use of adipose tissue (fat) sourced stem cell therapies for veterinary medicine.
If approved, this would become the first FDA-blessed, “off the shelf” regenerative cell therapy for treating osteoarthritis in dogs. As part of the deal, Aratana agreed to invest up to $5 million ($0.5 million contract signing + up to $4.5 million in milestone based payments) for R&D and to pay royalties on commercialization.
Aratana is a pet therapeutics company with a focus on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion animals. “Our sole focus is on solving the unmet and underserved medical needs of pets. Our entire approach to pet therapeutics is built around this single idea. We’re working to bring scientific advances from human health to pets and veterinary medicine.” said, Steven St. Peter, M.D., company president and CEO.
Vet-Stem creates stem cell technologies for veterinary medicine. The company develope...
